Open access · OA
via OpenAlex
Nicotinamide Mononucleotide (NMN) as a Solution of Decrease Nicotinamide Adenine Dinucleotide (NAD+) in Aging
Ni Kadek Mei Permatasari, I Gusti Ngurah Agung Krisna Widiantara Bagus Putra, Cokorda Agung Wahyu Purnamasidhi
International Journal of Research and Review · 2023
Abstract
Advances in the control of infectious diseases have contributed to increasing life expectancy. As a result, the aging population has increased. Data shows that there were 771 million elderly in 2022, which is estimated to increase to 1.6 billion in 2050. This condition causes changes in disease patterns that lead to diseases related to age and aging. Recently, nicotinamide mononucleotide (NMN) has received much attention. Therefore, the authors made this review article using the literature review method to describe role of NMN as an anti-aging modality and prevention of disease associated with a decrease in nicotinamide adenine dinucleotide (NAD+). Decreased NAD+ levels occur through several mechanisms, including activation of PARP-1 by oxidative stress, consumption of NAD+ by CD38 enzymes and sirtuins, injury induced by sterile alpha and toll/interleukin receptor motif-containing protein 1 (SARM1) in axon degeneration, and increased mitochondrial permeability transition (MPT). NMN can increase NAD+ levels in the Salvage and Preiss-Handler pathways so that they will make a positive impact on aging, Parkinson's, Alzheimer's, obesity, cerebral ischemia, heart disease, and type 2 diabetes. The administration of NMN in low doses does not cause significant side effects. Keywords: aging, anti-aging, NAD+, NMN
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.52403/ijrr.20230871
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Permatasari, N.K.M., Putra, I.G.N.A.K.W.B., & Purnamasidhi, �.A.W. (2023). Nicotinamide Mononucleotide (NMN) as a Solution of Decrease Nicotinamide Adenine Dinucleotide (NAD+) in Aging. <em>International Journal of Research and Review</em>. https://doi.org/10.52403/ijrr.20230871
Vancouver
Permatasari NKM, Putra IGNAKWB, Purnamasidhi �AW. Nicotinamide Mononucleotide (NMN) as a Solution of Decrease Nicotinamide Adenine Dinucleotide (NAD+) in Aging. International Journal of Research and Review. 2023. doi:10.52403/ijrr.20230871.
BibTeX
@article{ni2023Nicoti,
title = {Nicotinamide Mononucleotide (NMN) as a Solution of Decrease Nicotinamide Adenine Dinucleotide (NAD+) in Aging},
author = {Ni Kadek Mei Permatasari and I Gusti Ngurah Agung Krisna Widiantara Bagus Putra and Cokorda Agung Wahyu Purnamasidhi},
journal = {International Journal of Research and Review},
year = {2023},
doi = {10.52403/ijrr.20230871},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Rejuvenation Research 2017
Citation only
The NAD+/PARP1/SIRT1 Axis in Aging
Frontiers in Nutrition 2022
Open access · CC-BY
Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects
Current Opinion in Cardiology 2026
Citation only
Role of nicotinamide adenine dinucleotide in cardiovascular disease
Current opinion in cardiology 2026
Citation only
Role of nicotinamide adenine dinucleotide in cardiovascular disease.
Antioxidants and Redox Signaling 2018
Preprint · OA
Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes
Journal of Advanced Research 2021
Open access · CC-BY